Literature DB >> 4105464

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

T A Medsger, A T Masi, G P Rodnan, T G Benedek, H Robinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4105464     DOI: 10.7326/0003-4819-75-3-369

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  40 in total

Review 1.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

2.  Systemic sclerosis in the elderly.

Authors:  L Czirják; Z Nagy; G Szegedi
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

3.  Predictors of survival in 171 patients with systemic sclerosis (scleroderma).

Authors:  Z Nagy; L Czirják
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

Review 4.  Immunomodulatory therapy for SSc: will high-intensity immunosuppression with stem cell rescue improve outcome?

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

5.  Improving survival in inflammatory rheumatic diseases: a neglected goal?

Authors:  Theodore Pincus; Allan Gibofsky; J Timothy Harrington
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

6.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

7.  Sclerodermatomyositis with megacolon, small-bowel involvement and impaired lung function.

Authors:  V Srinivas
Journal:  Proc R Soc Med       Date:  1976-04

8.  Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.

Authors:  B Waeber; M D Schaller; J P Wauters; H R Brunner
Journal:  Klin Wochenschr       Date:  1984-08-01

Review 9.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 10.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.